Article
Publicly Available
International collaboration in drug discovery and development: the NCI experience
-
Gordon M. Cragg
Published/Copyright:
January 1, 2009
Published Online: 2009-01-01
Published in Print: 1999-09-01
© 2013 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Novel strategies for the discovery of plant-derived anticancer agents
- International collaboration in drug discovery and development: the NCI experience
- Bioconnectivity: a blueprint for biodiversity?
- Structure of 'endogenous ouabain'
- New approach in phytopharmacological research
- Importance of biodiversity to the modern pharmaceutical industry
- Brazilian phytochemical diversity: bioorganic compounds produced by secondary metabolism as a source of new scientific development, varied industrial applications and to enhance human health and the quality of life
- Recent progress of the research on novel microbial metabolites
- Single-tube single-colour multiplex PCR amplification of ten polymorphic microsatellites (ALF10): a new powerful tool for DNA profiling
- Kinetics in highly viscous solutions: dynamic solvent effects in 'slow' reactions
- Electrolyte solutions for technology - new aspects and approaches
- Solution structure of paramagnetic metalloproteins
- Metal ion-binding properties of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA). Why is its diphosphorylated form, PMEApp4-, initially a better substrate for nucleic acid polymerases than (2'-deoxy)-adenosine 5'-triphosphate (dATP4-/ATP4-)?
- New horizons in hydrogen bonded clusters in solution
- Electron tunneling in biological molecules
- Terminology for compounds in the Si-Al-O-N system
- A Critical Evaluation of the Redox Properties of Uranium, Neptunium and Plutonium Ions in Acidic Aqueous Solutions
- Errata: Atomic weights of the elements (Technical Report). Pure Appl. Chem. 71(8), 1593-1607 (1999)
Articles in the same Issue
- Novel strategies for the discovery of plant-derived anticancer agents
- International collaboration in drug discovery and development: the NCI experience
- Bioconnectivity: a blueprint for biodiversity?
- Structure of 'endogenous ouabain'
- New approach in phytopharmacological research
- Importance of biodiversity to the modern pharmaceutical industry
- Brazilian phytochemical diversity: bioorganic compounds produced by secondary metabolism as a source of new scientific development, varied industrial applications and to enhance human health and the quality of life
- Recent progress of the research on novel microbial metabolites
- Single-tube single-colour multiplex PCR amplification of ten polymorphic microsatellites (ALF10): a new powerful tool for DNA profiling
- Kinetics in highly viscous solutions: dynamic solvent effects in 'slow' reactions
- Electrolyte solutions for technology - new aspects and approaches
- Solution structure of paramagnetic metalloproteins
- Metal ion-binding properties of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA). Why is its diphosphorylated form, PMEApp4-, initially a better substrate for nucleic acid polymerases than (2'-deoxy)-adenosine 5'-triphosphate (dATP4-/ATP4-)?
- New horizons in hydrogen bonded clusters in solution
- Electron tunneling in biological molecules
- Terminology for compounds in the Si-Al-O-N system
- A Critical Evaluation of the Redox Properties of Uranium, Neptunium and Plutonium Ions in Acidic Aqueous Solutions
- Errata: Atomic weights of the elements (Technical Report). Pure Appl. Chem. 71(8), 1593-1607 (1999)